Extramedullary disease in Multiple Myeloma
Send us Fan Mail Extramedullary disease (EMD) represents an aggressive form of multiple myeloma, characterized by the ability of myeloma cells to form tumors outside the bone marrow independently. Sc...
7 Juli 202322min
Recent findings in MGUS
Send us Fan Mail Monoclonal gammopathy of undetermined significance, called MGUS, is a blood condition which indicates occurrence of clonal cells that secrete monoclonal immunoglobulins. MGUS as such,...
15 Apr 202344min
Waldenström Macroglobulinemia: a clinical update
Send us Fan Mail Waldenström Macroglobulinemia is a rare type of non-Hodgkin lymphoma affecting B-cells. Waldenström Macroglobulinemia is characterised by high levels of circulating antibodies, immuno...
27 Mars 202343min
Mental health during and after cancer treatment
Send us Fan Mail Mental health includes our emotional, psychological and social well-being. A physical illness can have a severe impact on mental health. As health care professionals we often focus pr...
14 Dec 202240min
Challenges in diagnosing Gaucher and other rare inherited metabolic disorders
Send us Fan Mail In this episode we will discuss rare, inherited metabolic disorders in general, as well diseases such as Gaucher and other diseases. These genetic conditions are very rare. They can b...
18 Okt 202237min
Hemoglobinopathies
Send us Fan Mail Hemoglobinopathies have previously been rare in the Nordic population but with increasing migration we now meet many patients with different types of thalassemias and hemoglobin varia...
30 Jan 202236min
MRD as primary endpoint
Send us Fan Mail Minimal residual disease (MRD) can today be evaluated in individual patient after treatment using various methods with high sensitivity. MRD indicates remaining malignant cells that c...
29 Nov 202140min
Minimal Residual Disease (MRD) - Cost vs Benefit
Send us Fan Mail Detection of Minimal Residual Disease (MRD) is becoming more important in different fields of hematology including Multiple Myeloma. Over the past decades we’ve been able to improve ...
28 Okt 202127min
